innovative IBD treatment - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

Care Career buys MAS Medical Staffing to expand healthcare workforce platform

China uses water cannon against Philippine vessels for second day near Scarborough Shoal

Energy Action reports A$12.2m FY2026 revenue as higher costs pressure earnings

IBM’s planned acquisition of HRL Laboratories could strengthen its quantum computing roadmap by adding silicon-spin qubit technology and expanding its advanced semiconductor research capabilities. Representative image.

Inside the quantum foundry race behind IBM’s move for HRL Laboratories

AbbVie and FutureGen to develop FG-M701, a promising therapy for inflammatory bowel disease, aiming to transform patient care.

Read More

Pharma Industry News

AbbVie, FutureGen joins forces to pioneer next-gen IBD treatment FG-M701

In a significant development in the pharmaceutical industry, AbbVie Inc. (NYSE: ABBV) and FutureGen Biopharmaceutical (Beijing) Co., Ltd.…

byPallavi Madhiraju

June 14, 2024

web analytics